Stay updated with breaking news from Splunk Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corporate bonds to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., according to people with knowledge of the matter.
(Bloomberg) -- Pharmaceutical giant AbbVie Inc. sold $15 billion of bonds in the US investment-grade market on Thursday to help fund its acquisitions of ImmunoGen Inc. and Cerevel Therapeutics Holdings Inc., adding to a recent rush of buyout financings. Most Read from BloombergNvidia Rises Most in About Nine Months as AI Drives SalesStocks Rally as AI Craze Sweeps Across the World: Markets WrapT-Bills Without Tax Bills? This Fund Says It Cracked the CodeAT&T Says Mobile Network Restored as US St
(Bloomberg) — Wall Street traders kept a lid on stocks ahead of results from Nvidia Corp. — the giant chipmaker at the heart of the artificial-intelligence frenzy that has powered the bull market. Just hours away from the company’s quarterly numbers, investors around the world are waiting to see whether Nvidia will be able to…
(Bloomberg) — Wall Street traders kept a lid on stocks ahead of results from Nvidia Corp. — the giant chipmaker at the heart of the artificial-intelligence frenzy that has powered the bull market. Treasury yields climbed after a $16 billion sale of 20-year bonds. Just hours away from the company’s quarterly numbers, investors around the…
NCino (NASDAQ:NCNO – Get Free Report) and Splunk (NASDAQ:SPLK – Get Free Report) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk and valuation. Valuation & Earnings This table compares nCino and […]